Related Experiment Video
Updated: Sep 26, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Myocarditis following COVID-19 mRNA (mRNA-1273) vaccination
Suresh Babu Chellapandian1, Suha Turkmen1,2, Imtiaz Salim3
1Department of Emergency Medicine Hamad Medical Corporation Doha Qatar.
Myocarditis, an inflammation of the heart muscle, is a rare complication following the COVID mRNA-1273 vaccine. While typically mild, healthcare professionals should remain vigilant for this post-vaccination condition.
Area of Science:
- Cardiology
- Vaccinology
- Immunology
Background:
- The widespread administration of mRNA vaccines, including mRNA-1273 (Moderna COVID-19 Vaccine), has been crucial in combating the COVID-19 pandemic.
- While generally safe and effective, rare adverse events following immunization require ongoing monitoring and characterization.
Observation:
- This case report details a patient who developed myocarditis, a rare cardiac complication, subsequent to receiving the mRNA-1273 vaccine.
- The clinical presentation of post-vaccine myocarditis can vary, with many cases exhibiting mild symptoms.
Findings:
- Myocarditis was identified as a rare but potential complication following mRNA-1273 vaccination.
- The observed case highlights the importance of recognizing myocarditis in the differential diagnosis of cardiac symptoms post-vaccination.
Implications:
- Healthcare providers should maintain awareness of the possibility of myocarditis developing after COVID-19 vaccination.
- Further research and surveillance are warranted to fully understand the incidence, risk factors, and clinical trajectory of post-vaccine myocarditis.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Pericarditis I: Introduction
Pericarditis III: Medical Management

